Long Term Outcome Data from the Eortc 75111-10114 Etf/Bcg Randomized Phase Ii Study: Pertuzumab and Trastuzumab with or Without Metronomic Chemotherapy for Older Patients with Her2-Positive Metastatic Breast Cancer, Followed by T-Dm1 After Progression

AuthID
 P-00W-R9F
12
Author(s)
Meyskens, T
·
Dal Lago, L
·
Vuylsteke, P
·
Curigliano, G
·
Waters, S
·
Meulemans, B
·
Sousa, B
·
Poncet, C
·
Document Type
Article
Year published
2022
Published
in BREAST, ISSN: 0960-9776
Volume: 64, Pages: 100-111 (12)
Indexing
Wos®
Scopus®
Pubmed®
Google Scholar®
Publication Identifiers
Pubmed: 35636341
Scopus: 2-s2.0-85131036839
Wos: WOS:000807506100004
Source Identifiers
ISSN: 0960-9776
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service